TC
BMY icon

TownSquare Capital’s Bristol-Myers Squibb BMY Stock Holding History

TownSquare Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$406K Buy
6,694
+873
+15% +$50.9K 0.09% 172
2025
Q4 		$314K Sell
5,821
-6,344
-52% -$305K 0.07% 186
2025
Q3 		$549K Sell
12,165
-6,857
-36% -$320K 0.08% 200
2025
Q2 		$881K Sell
19,022
-243,151
-93% -$11.9M 0.09% 226
2025
Q1 		$16M Buy
262,173
+34,874
+15% +$2.03M 0.17% 107
2024
Q4 		$12.9M Buy
227,299
+77,605
+52% +$4.34M 0.15% 126
2024
Q3 		$7.75M Buy
149,694
+25,324
+20% +$1.19M 0.09% 210
2024
Q2 		$5.17M Buy
124,370
+4,908
+4% +$220K 0.07% 257
2024
Q1 		$6.48M Buy
119,462
+6,806
+6% +$347K 0.09% 203
2023
Q4 		$5.78M Buy
112,656
+8,630
+8% +$453K 0.1% 197
2023
Q3 		$6.04M Sell
104,026
-8,541
-8% -$523K 0.11% 175
2023
Q2 		$7.2M Buy
112,567
+11,796
+12% +$791K 0.13% 159
2023
Q1 		$6.98M Buy
100,771
+5,519
+6% +$389K 0.15% 122
2022
Q4 		$6.85M Buy
95,252
+17,374
+22% +$1.31M 0.17% 115
2022
Q3 		$5.54M Buy
77,878
+8,359
+12% +$606K 0.16% 117
2022
Q2 		$5.35M Sell
69,519
-1,517
-2% -$116K 0.15% 120
2022
Q1 		$5.19M Buy
71,036
+13,999
+25% +$940K 0.13% 144
2021
Q4 		$3.56M Buy
57,037
+3,646
+7% +$214K 0.09% 189
2021
Q3 		$3.16M Buy
53,391
+4,968
+10% +$327K 0.09% 195
2021
Q2 		$3.23M Buy
48,423
+11,064
+30% +$721K 0.1% 170
2021
Q1 		$2.36M Buy
37,359
+3,528
+10% +$220K 0.09% 183
2020
Q4 		$2.1M Buy
33,831
+3,468
+11% +$213K 0.09% 182
2020
Q3 		$1.75M Sell
30,363
-2,221
-7% -$134K 0.1% 164
2020
Q2 		$1.88M Buy
32,584
+4,097
+14% +$245K 0.13% 133
2020
Q1 		$1.72M Sell
28,487
-743
-3% -$45.4K 0.14% 121
2019
Q4 		$1.88M Sell
29,230
-4,245
-13% -$243K 0.15% 119
2019
Q3 		$1.93M Buy
33,475
+2,974
+10% +$140K 0.16% 112
2019
Q2 		$1.4M Sell
30,501
-4,059
-12% -$189K 0.13% 125
2019
Q1 		$1.65M Buy
34,560
+12,915
+60% +$643K 0.13% 125
2018
Q4 		$1.08M Buy
+21,645
New +$1.16M 0.14% 130

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TownSquare Capital's BMY Position: Q1 2026 in Review

TownSquare Capital increased its Bristol-Myers Squibb (BMY) stake by 15% in Q1 2026, buying an estimated $50.9K and bringing the position to 6,694 shares worth $406K. The position accounts for 0.09% of the portfolio, ranked #172.

TownSquare Capital first reported a position in BMY in Q4 2018 and has held it in 30 quarters since. The position peaked at $16M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • TownSquare Capital held 6,694 shares of Bristol-Myers Squibb worth $406K as of Q1 2026.
  • TownSquare Capital bought 873 Bristol-Myers Squibb shares in Q1 2026, an estimated $50.9K.
  • Bristol-Myers Squibb made up 0.09% of TownSquare Capital's portfolio in Q1 2026, its #172 holding.
  • TownSquare Capital first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 30 quarters since.
  • TownSquare Capital's Bristol-Myers Squibb position peaked at $16M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on TownSquare Capital's 13F filing for Q1 2026, filed 13 May 2026.